JNBA Financial Advisors’s iBio IBIO Stock Holding History

JNBA Financial Advisors’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-31	Closed	-$84K	–	865
2016 Q3	$84K	Buy	+31	New	+$97.2K	0.01%	404

Other funds holding IBIO

ACP

Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

ACP

Aveo Capital Partners Englewood, Colorado $601M AUM 5.92% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

JNBA Financial Advisors's IBIO Position: Q4 2016 in Review

JNBA Financial Advisors sold out of iBio (IBIO) in Q4 2016, closing a stake of 31 shares — an estimated $84K sold.

JNBA Financial Advisors first reported a position in IBIO in Q3 2016 and held it in 1 quarter. The position peaked at $84K in Q3 2016. 17 funds tracked by Wall St. Rank hold IBIO as of Q4 2016.

JNBA Financial Advisors reported no remaining iBio position as of Q4 2016 after selling out during the quarter.
JNBA Financial Advisors sold 31 iBio shares in Q4 2016, an estimated $84K.
JNBA Financial Advisors first reported a position in iBio in Q3 2016 and held it in 1 quarter.
JNBA Financial Advisors's iBio position peaked at $84K in Q3 2016.
17 funds tracked by Wall St. Rank held iBio as of Q4 2016.

Based on JNBA Financial Advisors's 13F filing for Q4 2016, filed 3 Feb 2017.